U.S. Markets open in 28 mins

Top Ranked Momentum Stocks to Buy for November 12th

Zacks Equity Research

Here are four stocks with buy rank and strong momentum characteristics for investors to consider today, November 12th:

Itron, Inc. (ITRI): This technology and service company that provides end-to-end solutions that measures, manages, and analyzes energy and water use has a Zacks Rank #1 (Strong Buy) and witnessed the Zacks Consensus Estimate for its current year earnings increasing 6.6% over the last 60 days.

Itron, Inc. Price and Consensus

Itron, Inc. Price and Consensus

Itron, Inc. price-consensus-chart | Itron, Inc. Quote

Itron’s shares gained 5.8% over the last one month above the S&P 500’s increase 4.1%. The company possesses a Momentum Score of A.

Itron, Inc. Price

Itron, Inc. Price

Itron, Inc. price | Itron, Inc. Quote

ePlus, Inc. (PLUS): This company that provides information technology solutions that enable organizations to optimize their information technology environment and supply chain processes has a Zacks Rank #1 and witnessed the Zacks Consensus Estimate for its current year earnings increasing 12.2% over the last 60 days.

ePlus inc. Price and Consensus

ePlus inc. Price and Consensus

ePlus inc. price-consensus-chart | ePlus inc. Quote

ePlus’ shares gained 17.6% over the last one month. The company possesses a Momentum Score of A.

ePlus inc. Price

ePlus inc. Price

ePlus inc. price | ePlus inc. Quote

Guardant Health, Inc. (GH): This precision oncology company has a Zacks Rank #1 and witnessed the Zacks Consensus Estimate for its current year earnings increasing 30.7% over the last 60 days.

Guardant Health, Inc. Price and Consensus

Guardant Health, Inc. Price and Consensus

Guardant Health, Inc. price-consensus-chart | Guardant Health, Inc. Quote

Guardant Health’s shares gained 13.7% over the last one month. The company possesses a Momentum Score of A.

Guardant Health, Inc. Price

Guardant Health, Inc. Price

Guardant Health, Inc. price | Guardant Health, Inc. Quote

Genesis Healthcare, Inc. (GEN): This biopharmaceutical company has a Zacks Rank #1 and witnessed the Zacks Consensus Estimate for its current year earnings increasing 13% over the last 60 days.

Genesis Healthcare, Inc. Price and Consensus

Genesis Healthcare, Inc. Price and Consensus

Genesis Healthcare, Inc. price-consensus-chart | Genesis Healthcare, Inc. Quote

Genesis Healthcare’s shares gained 19.8% over the last one month. The company possesses a Momentum Score of A.

Genesis Healthcare, Inc. Price

Genesis Healthcare, Inc. Price

Genesis Healthcare, Inc. price | Genesis Healthcare, Inc. Quote

See the full list of top ranked stocks here

Learn more about the Momentum score and how it is calculated here.

Looking for Stocks with Skyrocketing Upside?

Zacks has just released a Special Report on the booming investment opportunities of legal marijuana.     

Ignited by new referendums and legislation, this industry is expected to blast from an already robust $6.7 billion to $20.2 billion in 2021. Early investors stand to make a killing, but you have to be ready to act and know just where to look.  

See the pot trades we're targeting>>


Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
ePlus inc. (PLUS) : Free Stock Analysis Report
 
Itron, Inc. (ITRI) : Free Stock Analysis Report
 
Guardant Health, Inc. (GH) : Free Stock Analysis Report
 
Genesis Healthcare, Inc. (GEN) : Free Stock Analysis Report
 
To read this article on Zacks.com click here.
 
Zacks Investment Research